One year in review 2018: systemic vasculitis

Elena Elefante; Milena Bond; Sara Monti; Gemma Lepri; Elena Cavallaro; Mara Felicetti; Emanuele Calabresi; Chiara Posarelli; Rosaria Talarico; Luca Quartuccio; Chiara Baldini

One year in review 2018: systemic vasculitis

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):12-32. Epub 2018 May 18.

Authors

Affiliations

¹ Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
² Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital 'Santa Maria della Misericordia', Udine, Italy.
³ Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
⁴ Department of Clinical and Experimental Medicine, Division of Rheumatology, University of Florence, AOUC, Florence, Italy.
⁵ Operative Unit of Rheumatology, Department of Medicine DIMED, University of Padova, Italy.
⁶ Ophthalmology Unit, Department of Surgical, Medical, Molecular Pathology and Emergency, University of Pisa, Italy.
⁷ Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. chiara.baldini74@gmail.com.

PMID: 29799395

Abstract

Systemic vasculitis are heterogeneous, complex and disabling disorders. Following the previous annual reviews of this series, this paper gives a brief overview on current knowledge about recent literature on small- and large-vessel systemic vasculitis, with a specific focus on pathogenetic and clinical aspects, novel possible disease-related biomarkers and current and future therapies that are in the pipeline.

Publication types

Review

MeSH terms

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology
Antirheumatic Agents / therapeutic use
Churg-Strauss Syndrome / drug therapy
Churg-Strauss Syndrome / immunology
Cryoglobulinemia / complications
Cryoglobulinemia / drug therapy
Cryoglobulinemia / immunology*
Giant Cell Arteritis / drug therapy
Giant Cell Arteritis / immunology
Granulomatosis with Polyangiitis / drug therapy
Granulomatosis with Polyangiitis / immunology
Hepatitis C, Chronic / complications
Hepatitis C, Chronic / immunology*
Humans
Immunosuppressive Agents / therapeutic use
Microscopic Polyangiitis / drug therapy
Microscopic Polyangiitis / immunology
Systemic Vasculitis / drug therapy
Systemic Vasculitis / etiology
Systemic Vasculitis / immunology*
Takayasu Arteritis / drug therapy
Takayasu Arteritis / immunology

Substances

Antirheumatic Agents
Immunosuppressive Agents